Correlation Between Recursion Pharmaceuticals and 59523UAP2
Specify exactly 2 symbols:
By analyzing existing cross correlation between Recursion Pharmaceuticals and MID AMERICA APTS L, you can compare the effects of market volatilities on Recursion Pharmaceuticals and 59523UAP2 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of 59523UAP2. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and 59523UAP2.
Diversification Opportunities for Recursion Pharmaceuticals and 59523UAP2
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Recursion and 59523UAP2 is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and MID AMERICA APTS L in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MID AMERICA APTS and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with 59523UAP2. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MID AMERICA APTS has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and 59523UAP2 go up and down completely randomly.
Pair Corralation between Recursion Pharmaceuticals and 59523UAP2
Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 14.95 times less return on investment than 59523UAP2. But when comparing it to its historical volatility, Recursion Pharmaceuticals is 8.5 times less risky than 59523UAP2. It trades about 0.03 of its potential returns per unit of risk. MID AMERICA APTS L is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 9,593 in MID AMERICA APTS L on September 12, 2024 and sell it today you would earn a total of 47.00 from holding MID AMERICA APTS L or generate 0.49% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 69.29% |
| Values | Daily Returns |
Recursion Pharmaceuticals vs. MID AMERICA APTS L
Performance |
| Timeline |
| Recursion Pharmaceuticals |
| MID AMERICA APTS |
Recursion Pharmaceuticals and 59523UAP2 Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Recursion Pharmaceuticals and 59523UAP2
The main advantage of trading using opposite Recursion Pharmaceuticals and 59523UAP2 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, 59523UAP2 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 59523UAP2 will offset losses from the drop in 59523UAP2's long position.| Recursion Pharmaceuticals vs. Absci Corp | Recursion Pharmaceuticals vs. Affimed NV | Recursion Pharmaceuticals vs. Sana Biotechnology | Recursion Pharmaceuticals vs. Relay Therapeutics |
| 59523UAP2 vs. AEP TEX INC | 59523UAP2 vs. US BANK NATIONAL | 59523UAP2 vs. Recursion Pharmaceuticals | 59523UAP2 vs. SoundHound AI |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |